DiscoverTT HealthWatchPost-MI Care, NSTEMI Revascularization, Afib Anticoagulation, and RSV Outcomes
Post-MI Care, NSTEMI Revascularization, Afib Anticoagulation, and RSV Outcomes

Post-MI Care, NSTEMI Revascularization, Afib Anticoagulation, and RSV Outcomes

Update: 2025-09-051
Share

Description

Program notes:

0:53 Who needs a beta blocker after MI

1:53 Those with mild reduction of ejection fraction

2:53 Confined to those with 40-50% ejection fraction

3:15 Revascularization in NSTEMI

4:20 Composite outcome

5:20 Closes gap, do FFR

6:20 May not be physiologically significant

6:40 Is lifelong anticoagulation needed after ablation

7:41 Occurred less in those who stopped

8:30 RSV, cardiac events and hospitalizations

9:30 Lower hospitalization in those who got the vaccine

10:30 Acute respiratory illness hospitalization

11:30 Less benefit with existing CVD or immunocompromise

12:15 Several RSV vaccines

13:16 End

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Post-MI Care, NSTEMI Revascularization, Afib Anticoagulation, and RSV Outcomes

Post-MI Care, NSTEMI Revascularization, Afib Anticoagulation, and RSV Outcomes

Elizabeth Tracey and Dr. Richard Lange